Case Studies: Urology and Women

Drs. Karl Luber, Peter K. Sand, and Raymond Rackley

Describe the pathophysiology of bladder overactivity; Assess the role of antimuscarinic drug therapy, vanilloid-receptor agonists, botulinum toxin, and ß3-dren-ergic replacement therapy in the management of bladder overactivity; Define the diagnostic role of urethral pressure profile studies; Review current data on the pathophysiology of IC; and Implement a therapeutic approach that promotes uroepithelial healing in patients with IC.